{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:52:05Z","timestamp":1791427925710,"version":"4.3.3"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG027012"],"award-info":[{"award-number":["R01 AG027012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY024596"],"award-info":[{"award-number":["R01 EY024596"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56 AG052973"],"award-info":[{"award-number":["R56 AG052973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Growth and differentiation factor 15 (GDF-15) has been associated with obesity, muscle wasting, and cachexia. The receptor for GDF-15 was recently identified in the brainstem and regulates food intake and metabolism. The relationship of plasma GDF-15 with the age-associated decline of muscle mass and strength, gait speed, and physical performance in adults has not been well characterized.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Plasma GDF-15, grip strength, 6-m gait speed, 400-m walking test time, lower extremity physical performance score, appendicular lean mass, and fat mass were measured in 194 healthy adult participants, aged 22\u201393 years, of the Baltimore Longitudinal Study of Aging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Plasma GDF-15 concentrations increased with age (p &amp;lt; .001) and were higher in whites compared with blacks and Asians (p = .04). Adults with higher plasma GDF-15 had slower 6-m gait speed, longer 400-m walking time, and lower physical performance score in multivariable analyses adjusting for age and race. Plasma GDF-15 was not associated with grip strength, appendicular lean mass, or fat mass.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Elevated plasma GDF-15 is associated with slower gait speed, higher 400-m walking time, and lower physical performance in very healthy community-dwelling adults. The relationship between plasma GDF-15 and sarcopenia-related outcomes may be stronger in the population not selected to be healthy, and this hypothesis should be tested in a representative population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/gerona\/glz071","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T09:38:01Z","timestamp":1552642681000},"page":"175-180","source":"Crossref","is-referenced-by-count":82,"title":["Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults"],"prefix":"10.1093","volume":"75","author":[{"given":"Richard D","family":"Semba","sequence":"first","affiliation":[{"name":"Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gonzalez-Freire","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Biancotto","sequence":"additional","affiliation":[{"name":"Trans-NIH Center for Human Immunology, Autoimmunity, and Inflammation, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingbo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Shardell","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruin","family":"Moaddel","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CHI Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"2019121307581503800_CIT0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1532-5415.2004.52014.x","article-title":"The healthcare costs of sarcopenia in the United States","volume":"52","author":"Janssen","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"2019121307581503800_CIT0002","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1159\/000382052.","article-title":"Sarcopenia in older adults","volume":"24","author":"Walston","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2019121307581503800_CIT0003","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0531-5565(01)00220-0","article-title":"The biochemistry of aging muscle","volume":"37","author":"Carmeli","year":"2002","journal-title":"Exp Gerontol"},{"key":"2019121307581503800_CIT0004","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1152\/japplphysiol.00347.2003","article-title":"Invited review: aging and sarcopenia","volume":"95","author":"Doherty","year":"2003","journal-title":"J Appl Physiol (1985)"},{"key":"2019121307581503800_CIT0005","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1152\/jappl.1991.71.2.644","article-title":"A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women","volume":"71","author":"Frontera","year":"1991","journal-title":"J Appl Physiol (1985)"},{"key":"2019121307581503800_CIT0006","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1532-5415.2002.50217.x","article-title":"Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study","volume":"50","author":"Visser","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"2019121307581503800_CIT0007","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","article-title":"Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability","volume":"50","author":"Janssen","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"2019121307581503800_CIT0008","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJM199710303371806","article-title":"Falls, injuries due to falls, and the risk of admission to a nursing home","volume":"337","author":"Tinetti","year":"1997","journal-title":"N Engl J Med"},{"key":"2019121307581503800_CIT0009","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"key":"2019121307581503800_CIT0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jama.281.6.558","article-title":"Midlife hand grip strength as a predictor of old age disability","volume":"281","author":"Rantanen","year":"1999","journal-title":"JAMA"},{"key":"2019121307581503800_CIT0011","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1034\/j.1600-0579.2003.00207.x","article-title":"Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism","volume":"51","author":"Rantanen","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"2019121307581503800_CIT0012","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"2019121307581503800_CIT0013","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2019121307581503800_CIT0014","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12603-011-0092-7","article-title":"Sarcopenia: designing phase IIB trials","volume":"15","author":"Chumlea","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"2019121307581503800_CIT0015","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"2019121307581503800_CIT0016","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/ijo.2015.242","article-title":"Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1\/GDF15","volume":"40","author":"Tsai","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"2019121307581503800_CIT0017","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann Neurol"},{"key":"2019121307581503800_CIT0018","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/08977194.2011.607137","article-title":"The TGF-\u03b2 superfamily cytokine, MIC-1\/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism","volume":"29","author":"Breit","year":"2011","journal-title":"Growth Factors"},{"key":"2019121307581503800_CIT0019","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1158\/0008-5472.CAN-04-3827","article-title":"The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome","volume":"65","author":"Bauskin","year":"2005","journal-title":"Cancer Res"},{"key":"2019121307581503800_CIT0020","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jir.2009.0052","article-title":"The TGF-beta superfamily cytokine MIC-1\/GDF15: secretory mechanisms facilitate creation of latent stromal stores","volume":"30","author":"Bauskin","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"2019121307581503800_CIT0021","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat Med"},{"key":"2019121307581503800_CIT0022","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"key":"2019121307581503800_CIT0023","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat Med"},{"key":"2019121307581503800_CIT0024","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"2019121307581503800_CIT0025","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cger.2017.02.004","article-title":"Anorexia of aging: assessment and management","volume":"33","author":"Landi","year":"2017","journal-title":"Clin Geriatr Med"},{"key":"2019121307581503800_CIT0026","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/jcsm.12192","article-title":"Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia","volume":"8","author":"Morley","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2019121307581503800_CIT0027","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/onc.2015.95","article-title":"NAG-1\/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway","volume":"35","author":"Min","year":"2016","journal-title":"Oncogene"},{"key":"2019121307581503800_CIT0028","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ggi.12724","article-title":"Secreted growth differentiation factor\u200915 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders","volume":"16","author":"Fujita","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"2019121307581503800_CIT0029","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-018-0744-0","article-title":"GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2","volume":"37","author":"Li","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"2019121307581503800_CIT0030","doi-asserted-by":"publisher","first-page":"e12799","DOI":"10.1111\/acel.12799","article-title":"Plasma proteomic signature of age in healthy humans","volume":"17","author":"Tanaka","year":"2018","journal-title":"Aging Cell"},{"key":"2019121307581503800_CIT0031","volume-title":"Normal Human Aging: The Baltimore Longitudinal Study of Aging","author":"Shock","year":"1984"},{"key":"2019121307581503800_CIT0032","doi-asserted-by":"publisher","first-page":"e003525","DOI":"10.1161\/CIRCEP.115.003525","article-title":"Atrial fibrillation and declining physical performance in older adults: the health, aging, and body composition study","volume":"9","author":"Magnani","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2019121307581503800_CIT0033","doi-asserted-by":"publisher","first-page":"e26332","DOI":"10.1371\/journal.pone.0026332","article-title":"From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay","volume":"6","author":"Kraemer","year":"2011","journal-title":"PLoS One"},{"key":"2019121307581503800_CIT0034","doi-asserted-by":"publisher","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of Variability in the SOMAscan Assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci Rep"},{"key":"2019121307581503800_CIT0035","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin Chem"},{"key":"2019121307581503800_CIT0036","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1016\/j.dsx.2015.09.016","article-title":"Diabetes mellitus related biomarker: the predictive role of growth-differentiation factor-15","volume":"10","author":"Berezin","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"2019121307581503800_CIT0037","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.bcp.2012.11.025","article-title":"The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer","volume":"85","author":"Wang","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"2019121307581503800_CIT0038","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1681\/ASN.2016080919","article-title":"Growth differentiation factor-15 and risk of CKD Progression","volume":"28","author":"Nair","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2019121307581503800_CIT0039","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1373\/clinchem.2006.076828","article-title":"Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay","volume":"53","author":"Kempf","year":"2007","journal-title":"Clin Chem"},{"key":"2019121307581503800_CIT0040","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1373\/clinchem.2012.190322","article-title":"Clinical and genetic correlates of growth differentiation factor 15 in the community","volume":"58","author":"Ho","year":"2012","journal-title":"Clin Chem"},{"issue":"Spec No 2","key":"2019121307581503800_CIT0041","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/gerona\/56.suppl_2.65","article-title":"Dietary intake, dietary patterns, and changes with age: an epidemiological perspective","volume":"56","author":"Wakimoto","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2019121307581503800_CIT0042","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cger.2015.04.012","article-title":"Anorexia of aging","volume":"31","author":"Visvanathan","year":"2015","journal-title":"Clin Geriatr Med"},{"key":"2019121307581503800_CIT0043","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00394-012-0437-y","article-title":"Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study","volume":"52","author":"Landi","year":"2013","journal-title":"Eur J Nutr"},{"key":"2019121307581503800_CIT0044","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jamda.2009.12.088","article-title":"Anorexia, physical function, and incident disability among the frail elderly population: results from the ilSIRENTE study","volume":"11","author":"Landi","year":"2010","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"2019121307581503800_CIT0045","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12725","article-title":"Skeletal muscle ex vivo mitochondrial respiration parallels decline in vivo oxidative capacity, cardiorespiratory fitness, and muscle strength: the Baltimore Longitudinal Study of Aging","volume":"17","author":"Gonzalez-Freire","year":"2018","journal-title":"Aging Cell."},{"key":"2019121307581503800_CIT0046","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/gerona\/glu012","article-title":"Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project","volume":"69","author":"McLean","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2019121307581503800_CIT0047","doi-asserted-by":"publisher","first-page":"e55174","DOI":"10.1371\/journal.pone.0055174","article-title":"TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"key":"2019121307581503800_CIT0048","doi-asserted-by":"publisher","first-page":"e34868","DOI":"10.1371\/journal.pone.0034868","article-title":"Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets","volume":"7","author":"Macia","year":"2012","journal-title":"PLoS One"},{"key":"2019121307581503800_CIT0049","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/oby.20638","article-title":"Lower NLRP3 inflammasome activity in NAG-1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity","volume":"22","author":"Wang","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"2019121307581503800_CIT0050","doi-asserted-by":"publisher","first-page":"690","DOI":"10.18632\/aging.100687","article-title":"hNAG-1 increases lifespan by regulating energy metabolism and insulin\/IGF-1\/mTOR signaling","volume":"6","author":"Wang","year":"2014","journal-title":"Aging (Albany NY)"},{"key":"2019121307581503800_CIT0051","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4093\/dmj.2014.38.6.472","article-title":"GDF15 Is a novel biomarker for impaired fasting glucose","volume":"38","author":"Hong","year":"2014","journal-title":"Diabetes Metab J"},{"key":"2019121307581503800_CIT0052","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1373\/clinchem.2016.254755","article-title":"Growth differentiation factor 15, Its 12-month relative change, and risk of cardiovascular events and total mortality in patients with stable coronary heart disease: 10-year follow-up of the KAROLA Study","volume":"62","author":"Dallmeier","year":"2016","journal-title":"Clin Chem"},{"key":"2019121307581503800_CIT0053","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1373\/clinchem.2016.260570","article-title":"Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease","volume":"63","author":"Hagstr\u00f6m","year":"2017","journal-title":"Clin Chem"},{"key":"2019121307581503800_CIT0054","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.molmed.2017.10.005","article-title":"Targeting obesity and cachexia: identification of the GFRAL Receptor-MIC-1\/GDF15 Pathway","volume":"23","author":"Breit","year":"2017","journal-title":"Trends Mol Med"}],"container-title":["The Journals of Gerontology: Series A"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/75\/1\/175\/31509313\/glz071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/75\/1\/175\/31509313\/glz071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T07:58:36Z","timestamp":1576223916000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/75\/1\/175\/5381536"}},"subtitle":[],"editor":[{"given":"Anne","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,15]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glz071","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,3,15]]}}}